We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Surgery Makes Dementia Patients Faster and Smarter

By HospiMedica International staff writers
Posted on 19 Apr 2011
A new study demonstrates that a cerebrospinal fluid (CSF) shunt can improve gait and cognition in patients with dementia caused by white matter changes and hydrocephalus. More...


Researchers from the Sahlgrenska Academy at the University of Gothenburg (Sweden) and Sahlgrenska University Hospital (Gothenburg, Sweden) conducted a randomized controlled double-blind study involving 14 consecutive idiopathic normal pressure hydrocephalus (iNPH) patients with extensive vascular white matter disease and normal cerebrospinal fluid (CSF) dynamics. Once determined they would benefit from shunt surgery for CSF drainage, the patients were randomized to receive either open or closed shunts. At 3 months after surgery, the patients with initially ligated shunts had their shunts opened. Clinical evaluation consisting of seven quantitative psychometric and six continuous gait tests were performed preoperatively, and three and six months after surgery.

The results showed that the patients randomized to receive open shunts had improved motor (30% increase) and psychometric (23% increase) scores three months after shunt placement; there were no significant changes between the three- and six-month follow-up in these same patients. Conversely, those with initially ligated shunts were unchanged during the first three-month period, although they improved in both motor (28%) and cognitive (18%) functions following removal of the ligature. The study was published early online on January 14, 2011, in the American Journal of Neurosurgery.

"Shunt operations have long been used for hydrocephalus, but this study offers more scientifically conclusive results to support the effect of the treatment, and also shows that shunt operations can help far more patients than previously believed with their walking and memory,” said lead author Magnus Tisell, MD, PhD, docent at the Sahlgrenska Academy and consultant neurosurgeon at Sahlgrenska University Hospital.

Hydrocephalus is caused by excessive CSF collecting in the brain's cavities. Patients often have problems walking, and their ability to think and remember is also affected. The fluid can be drained through a shunt, a narrow plastic tube that is surgically inserted into one of the brain's cavities and linked to the stomach or heart. In some cases, laparoscopic surgery can make it possible for the fluid to be absorbed into the bloodstream.

Related Links:
Sahlgrenska Academy at the University of Gothenburg
Sahlgrenska University Hospital



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.